Smoldering Systemic Mastocytosis
2 clinical trials · Condition
◉ Watch Smoldering Systemic Mastocytosis
| Record | Firm | Date |
|---|---|---|
| (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis (NCT05186753) | Cogent Biosciences, Inc. | 2022-06-27 |
| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis (NCT04910685) | Blueprint Medicines Corporation | 2021-11-30 |
Track Smoldering Systemic Mastocytosis automatically
Every clearance here is in the API, with alerts when new ones post.